About This EventSprout Social (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, visits the Nasdaq MarketSite in Times Square to celebrate its 15 years in ...

Avantis U.S. Quality ETF], visits the Nasdaq MarketSite in Times Square to celebrate their newly listed exchange traded fund (ETF).In honor of the occasion, Ted Randall, VP Senior Portfolio Manager, ...

About This EventWebull Corporation (Nasdaq: BULL), the owner of leading online investment platform, Webull, visits the Nasdaq MarketSite in Times Square to celebrate its recent public listing.In honor ...

Dollar Tree (Nasdaq: DLTR) visits the Nasdaq MarketSite in Times Square. Known for providing a “thrill-of-the-hunt” shopping experience, Dollar Tree is proud to celebrate its 30 th anniversary ...

About This EventGolub Capital BDC, Inc. (Nasdaq: GBDC), visits the Nasdaq MarketSite in Times Square to mark its 15th anniversary of being listed on the exchange. GBDC is an externally managed, ...

Microsoft (Nasdaq: MSFT) visits the Nasdaq MarketSite in Times Square to mark its 50 years since the technology company's founding. In honor of the occasion, Shelley Bransten, Corporate Vice ...

About This EventRuanyun Edai Technology Inc. (Nasdaq: RYET), a leading artificial intelligence (AI) technology company focused on K-12 education in China, visits the Nasdaq MarketSite in Times Square.

and Thinkproject — on the iconic Nasdaq billboard in Times Square. The “Global Leaders Scaling with AI” campaign was launched on April 21, 2025, to recognize innovators who are using AI to ...

Sanofi (Nasdaq: SNY) with We Are ILL, Inc., visits the Nasdaq MarketSite in Times Square. A patient advocacy organization, We Are ILL redefines what “sick” looks like by making the multiple ...

Wing VC visits the Nasdaq MarketSite in Times Square to celebrate the winners of the 7 th Annual Enterprise Tech 30 list, with the winning companies participating in the ceremony. In honor of the ...

About This EventTvardi Therapeutics, Inc. (Nasdaq: TVRD), a clinical-stage biopharmaceutical company developing novel STAT3 inhibitors for fibrosis-driven diseases, visits the Nasdaq MarketSite in ...